In October 2018, LMG Life Sciences rated Williams & Connolly "highly recommended", the publication's highest standing, in the areas of General Patent Litigation, Hatch-Waxman Patent Litigation (Branded), and Product Liability. The publication praised the firm's patent litigation group for its "position as a leading practice in biosimilars litigations" and the Products Liability group for its "nearly uninterrupted streak of wins."
LMG Life Sciences also recognized Partners David Berl, Jessamyn Berniker, Dane Butswinkas, Paul Gaffney, Bruce Genderson, Lane Heard, Heidi Hubbard, Enu Mainigi, Joseph Petrosinelli, Thomas Selby, and Senior Counsel Richard Cooper as 2018 “Life Science Stars”.
Earlier this year, the firm was honored with three awards at the 2018 LMG Life Sciences Awards Dinner in New York City. Williams & Connolly was recognized as Litigation Firm of the Year. The firm also received the Hatch-Waxman Impact Case of the Year award for its work on Eli Lilly & Co. v. Dr. Reddy’s Laboratories. In addition, partner Thomas Fletcher was named a U.S. Rising Star in Intellectual Property. The awards, which are selected based on a survey of peers and leading companies in the life sciences industry, “recognize and honor the leading attorneys, firms and in-house counsel teams, which have played a significant role in the life sciences industry over the past year.”
Click here to read the firm’s full profile in LMG Life Sciences.